180 Life Sciences Corp. Common Stock

Go to 180 Life Sciences Corp. Common Stock Website

$3.13

-0.23 (-6.85%)
Live
Previous Close

$3.36

Day Range

$0 - $0

Previous Day Range

$3.05 - $3.55

Market Cap

$19.2 million USD

Day Vol.

0

Previous Day Vol.

2.6 million

Currency

USD

Primary Exchange

Nasdaq

180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination the...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Elray Resources Inc. has completed the sale of its proprietary technology to 180 Life Sciences Corp. in exchange for preferred stock and warrants. This strategic move is expected to enhance Elray's financial position and enable collaboration with leading players in the market.

Related tickers: ELRA, ATNF, ATNFW.

Read Full Article

PALO ALTO, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Hearings Panel has determined to grant the Company’s request to continue its listing on The Nasdaq Stock Market, subject to the Company meeting certain conditions, including filing on or before July 31, 2024, a public disclosure describing the transactions undertaken by the Company to achieve compliance with Nasdaq’s continued listing rules and demonstrate long-term compliance with the Equity Rule (defined below) and providing an indication of its equity following those transactions.

Related tickers: ATNF.

Read Full Article
Trending Tickers

Please sign in to view